ULTRATAG Drug Patent Profile
Which patents cover Ultratag, and what generic alternatives are available?
Ultratag is a drug marketed by Curium and is included in one NDA.
The generic ingredient in ULTRATAG is technetium tc-99m red blood cell kit. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m red blood cell kit profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ULTRATAG?
- What are the global sales for ULTRATAG?
- What is Average Wholesale Price for ULTRATAG?
Summary for ULTRATAG
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in ULTRATAG? | ULTRATAG excipients list |
| DailyMed Link: | ULTRATAG at DailyMed |
US Patents and Regulatory Information for ULTRATAG
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Curium | ULTRATAG | technetium tc-99m red blood cell kit | INJECTABLE;INJECTION | 019981-001 | Jun 10, 1991 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ULTRATAG
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Curium | ULTRATAG | technetium tc-99m red blood cell kit | INJECTABLE;INJECTION | 019981-001 | Jun 10, 1991 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
